NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) today announced that its shareholders and the general public are invited to access its virtual-only 2022 Annual Meeting of Shareholders at 9:00 a.m. EDT on Thursday, April 14 28 2022. We have designed the virtual Annual Meeting to ensure that our shareholders who attend the virtual-only Annual Meeting will be afforded rights and opportunities to participate comparable to those they would have at an in-person meeting.

Effective today, shareholders can find additional information about accessing and registering for the virtual meeting at www.meetnow.global/MWPVZT2. On the day of the annual meeting, shareholders can begin logging into the virtual meeting platform at 8:45 a.m. EDT using either the control number on their proxy card, voting instruction form or notice previously received. Only shareholders who log into the meeting using a control number will be able to ask questions or vote at the live meeting.

Shareholders may also submit questions prior to the Meeting by following the instructions provided in the “Rules of Meeting Conduct and Procedure” available on the Virtual Meeting Platform. The deadline for submitting questions prior to the meeting is April 26 at 5:00 p.m. EDT. Registered Shareholders and Most Beneficial Shareholders will be able to vote for their Shares at the Meeting by following the instructions provided on the Virtual Meeting Platform. Certain beneficial owners may be required to obtain a legal proxy and pre-register for the virtual meeting in order to vote or ask questions at the live meeting. Beneficial owners should check with their broker if pre-registration is required. Additionally, beneficial owners will need to obtain a legal power of attorney and pre-register in order to submit questions ahead of the live meeting.

Guests can participate in listen-only mode. No control number is required. A replay of the webcast will be available for up to one year at: https://investors.pfizer.com/Investors/Events–Presentations/default.aspx

About Pfizer: Breakthroughs That Change Patients’ Lives

At Pfizer, we apply science and our global resources to bring people therapies that dramatically extend and improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of healthcare products, including innovative medicines and vaccines. Every day, Pfizer colleagues work in developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. In line with our responsibility as one of the world’s leading innovative biopharmaceutical companies, we work with healthcare providers, governments and local communities to support and expand access to reliable and affordable healthcare in the whole world. For over 170 years, we’ve worked to make a difference for everyone who counts on us. We regularly post information that may be important to investors on our website at www.Pfizer.com. Also, to learn more, visit us at www.Pfizer.com and follow us on Twitter at @Pfizer and @PfizerNewsLinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.

Notice of Disclosure: The webcast may include forward-looking statements regarding, among other things, our expected operating and financial performance, reorganizations, strategy, business plans and outlook; expectations regarding our product pipeline, product line and product candidates, including expected regulatory submissions, data readouts, study initiations, approvals, clinical trial results and other data in development , revenue contribution, growth, performance, timing of exclusivity and potential benefits; strategic reviews; capital allocation targets; dividends and share buybacks; plans and prospects for our acquisitions, divestitures and other business development activities, and our ability to successfully capitalize on these opportunities; manufacture and supply of products; and our efforts to respond to COVID-19, including our development of a vaccine to help prevent COVID-19 and the treatment of COVID-19, which are subject to substantial risks and uncertainties that could cause actual results differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and its subsequent reports on Form 10-Q, including in the sections titled “Factors of Risk” and “Forward-Looking Information and Factors That Could Affect Future Results,” as well as in its subsequent reports on Form 8-K, all of which are filed with the United States Securities and Exchange Commission and available at www.sec .gov and www. pfizer.com.

Forward-looking statements contained in the webcast speak only as of the original date of the webcast. Pfizer undertakes no obligation to update any forward-looking statements contained in the webcast as a result of new information or future events or developments.

Category: Financial

See the source version on businesswire.com: https://www.businesswire.com/news/home/20220419005233/en/

Media:

[email protected]

+1 (212) 733-1226

Investor:

[email protected]

+1 (212) 733-4848

Source: Pfizer Inc.